Aquatic Capital Management LLC Hutchmed (China) LTD Transaction History

Aquatic Capital Management LLC

  • $3.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$16.36 - $21.78 $27,812 - $37,026
1,700 New
1,700 $29,000
Q3 2022

Nov 14, 2022
BUY
$8.63 - $15.52 $55,232 - $99,328
6,400 New
6,400 $57,000
Q2 2022

Aug 15, 2022
SELL
$8.59 - $20.77 $859 - $2,077
-100 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$15.52 - $35.65 $72,944 - $167,555
-4,700 Reduced 97.92%
100 $2,000
Q4 2021

Feb 14, 2022
BUY
$28.89 - $35.33 $138,672 - $169,584
4,800 New
4,800 $168,000

Others Institutions Holding HCM

# of Institutions
65
Shares Held
6.88M
Call Options Held
6.2K
Put Options Held
1.1K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email